TriLink BioTechnologies社 March TriLink Messenger
|
|
|
 |
|
| Research News | |
|
Combating HIV/AIDS with mRNA Vaccines & CRISPR Gene Editing |
|
|
According to UNAIDS data for 2020, there were 1.5 million new infections and 680,000 AIDS-related deaths globally with 38 million people living with HIV infection. This blog explores promising progress toward anti-HIV mRNA vaccines for prophylaxis and CRISPR-based gene editing of HIV proviral DNA as a cure. |
|
|
|
 |
|
Quantifying N6-methyladenosine broadly and specifically with the new eTAM-seq method |
Identifying an epicardial cell subset that drives cardiac repair |
|
A new Nature Biotechnology publication describes how TriLink’s N6-Methyladenosine-5'-Triphosphate enabled the validation eTAM-seq. This new technique provides an accurate way to identify and quantify sites of m6A on transcriptome-wide or single-site scales. |
Researchers at Weill Cornell Medical College and the Icahn School of Medicine at Mount Sinai used TriLink’s CleanCap® technology to identify an epicardial progenitor cell subpopulation that drives heart repair and regeneration in zebrafish. |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
